Prostate 2013-12-01

MSMB gene variant alters the association between prostate cancer and number of sexual partners.

Marni Stott-Miller, Jonathan L Wright, Janet L Stanford

文献索引:Prostate 73(16) , 1803-9, (2013)

全文:HTML全文

摘要

Recently, a genetic variant (rs10993994) in the MSMB gene associated with prostate cancer (PCa) risk was shown to correlate with reduced prostate secretory protein of 94 amino acids (PSP94) levels. Although the biological activity of PSP94 is unclear, one of its hypothesized functions is to protect prostatic cells from pathogens. Number of sexual partners and a history of sexually transmitted infections (STIs) have been positively associated with PCa risk, and these associations may be related to pathogen-induced chronic prostatic inflammation. Based on these observations, we investigated whether MSMB genotype modifies the PCa-sexual history association.We estimated odds ratios (ORs) and 95% confidence intervals (CIs) for the association between number of sexual partners and PCa by fitting logistic regression models, stratified by MSMB genotype, and adjusted for age, family history of PCa, and PCa screening history among 1,239 incident cases and 1,232 controls.Compared with 1-4 female sexual partners, men with ≥ 15 such partners who carried the variant T allele of rs10993994 were at increased risk for PCa (OR = 1.32; 95% CI, 1.03-1.71); no association was observed in men with the CC genotype (OR = 1.03; 95% CI, 0.73-1.46; P = 0.05 for interaction). Similar estimates were observed for total sexual partners (any T allele OR = 1.37; 95% CI, 1.07-1.77; CC genotype OR = 1.11; 95% CI, 0.79-1.55; P = 0.06 for interaction).The rs10993994 genotype in the MSMB gene modifies the association between number of sexual partners and PCa risk. These findings support a hypothesized biological mechanism whereby prostatic infection/inflammation may enhance risk of PCa.© 2013 Wiley Periodicals, Inc.


相关化合物

  • Seminal Plasma In...

相关文献:

PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer.

2014-01-01

[Cell Death Dis. 5 , e1407, (2014)]

Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.

2003-05-01

[Cancer Res. 63(9) , 2072-8, (2003)]

Studies on the carboxyl terminal peptides of human seminal plasma inhibin (HSPI). Chemical synthesis and in vivo biological activity of the disulfide loop peptide 67-94 of HSPI.

1993-08-01

[Int. J. Pept. Protein Res. 42 , 132, (1993)]

beta 2-Inhibin contains the active core of human seminal plasma beta-inhibin: synthesis and bioactivity.

1985-02-11

[FEBS Lett. 181(1) , 57-63, (1985)]

更多文献...